Teva Pharma drops migraine drug patent case against Eli Lilly Ruchika Sharma29 Nov 2023 1:30 PM ISTUnited States: Israel-based drugmaker Teva Pharmaceuticals has agreed to end a patent lawsuit over Eli Lilly's migraine drug Emgality...
Sanofi-Teva Pharma to co-develop, co-commercialize inflammatory bowel disease treatment Ruchika Sharma5 Oct 2023 2:30 PM ISTParis: Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. have announced a collaboration to co-develop and...
Glenmark, Teva to pay Rs 2118 crore over drug price-fixing Ruchika Sharma22 Aug 2023 1:30 PM ISTUnder the agreement, federal prosecutors will dismiss the charges in three years if the companies abide by the settlement terms.
Teva, Alvotech secure US license date for AVT04, a proposed biosimilar to Stelara Ruchika Sharma13 Jun 2023 1:30 PM ISTIceland: Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...
AbbVie, Teva finalize USD 6.6 billion US opioid settlements Ruchika Sharma24 Nov 2022 4:27 PM ISTUS: Teva Pharmaceutical Industries Ltd and AbbVie Inc have finalized the terms of settlements worth more than $6.6 billion to resolve...
Sandoz, Teva Pharma plans to ramp up biosimilars production Ruchika Sharma23 Nov 2022 1:30 PM ISTTeva Chief Executive KÃ¥re Schultz said the company was targeting "80% of what's going off-patent in the next 10 years" including big sellers like the...
Former Sandoz Chief Richard Francis joins Teva Pharma as President, CEO Ruchika Sharma22 Nov 2022 1:30 PM ISTPrior to his role at Sandoz, Mr. Francis was a senior executive at Biogen for 13 years where he held a number of senior roles, including leading the...
Eli Lilly ordered to pay Rs 1444 crore to Teva Pharma in US migraine drug patent trial Ruchika Sharma10 Nov 2022 2:00 PM ISTThe jury also found that Lilly infringed the patents willfully and rejected its argument that the patents were invalid.
